Skip to main content
PMC home page
Journal of Epidemiology and Community Health logoLink to Journal of Epidemiology and Community Health
. 2000 Sep;54(9):697–702. doi: 10.1136/jech.54.9.697

Cost and health consequences of reducing the population intake of salt

R Selmer 1, I S Kristiansen 1, A Haglerod 1, S Graff-Iversen 1, H Larsen 1, H Meyer 1, K Bonaa 1, D Thelle 1
PMCID: PMC1731748  PMID: 10942450

Abstract

STUDY OBJECTIVE—The aim was to estimate health and economic consequences of interventions aimed at reducing the daily intake of salt (sodium chloride) by 6 g per person in the Norwegian population. Health promotion (information campaigns), development of new industry food recipes, declaration of salt content in food and taxes on salty food/subsidies of products with less salt, were possible interventions.
DESIGN—The study was a simulation model based on present age and sex specific mortality in Norway and estimated impact of blood pressure reductions on the risks of myocardial infarction and stroke as observed in Norwegian follow up studies. A reduction of 2 mm Hg systolic blood pressure (range 1-4) was assumed through the actual interventions. The cost of the interventions in themselves, welfare losses from taxation of salty food/subsidising of food products with little salt, cost of avoided myocardial infarction and stroke treatment, cost of avoided antihypertensive treatment, hospital costs in additional life years and productivity gains from reduced morbidity and mortality were included.
RESULTS—The estimated increase in life expectancy was 1.8 months in men and 1.4 in women. The net discounted (5%) cost of the interventions was minus $118 millions (that is, cost saving) in the base case. Sensitivity analyses indicate that the interventions would be cost saving unless the systolic blood pressure reduction were less than 2 mm Hg, productivity gains were disregarded or the welfare losses from price interventions were high.
CONCLUSION—Population interventions to reduce the intake of salt are likely to improve the population's health and save costs to society.


Keywords: sodium; hypertension; cost effectiveness

Full Text

The Full Text of this article is available as a PDF (126.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barendregt J. J., Bonneux L., van der Maas P. J. The health care costs of smoking. N Engl J Med. 1997 Oct 9;337(15):1052–1057. doi: 10.1056/NEJM199710093371506. [DOI] [PubMed] [Google Scholar]
  2. Beckmann S. L., Os I., Kjeldsen S. E., Eide I. K., Westheim A. S., Hjermann I. Effect of dietary counselling on blood pressure and arterial plasma catecholamines in primary hypertension. Am J Hypertens. 1995 Jul;8(7):704–711. doi: 10.1016/0895-7061(95)00122-6. [DOI] [PubMed] [Google Scholar]
  3. Collins R., Peto R., MacMahon S., Hebert P., Fiebach N. H., Eberlein K. A., Godwin J., Qizilbash N., Taylor J. O., Hennekens C. H. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990 Apr 7;335(8693):827–838. doi: 10.1016/0140-6736(90)90944-z. [DOI] [PubMed] [Google Scholar]
  4. Cook N. R., Cohen J., Hebert P. R., Taylor J. O., Hennekens C. H. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med. 1995 Apr 10;155(7):701–709. [PubMed] [Google Scholar]
  5. Ellekjaer H., Holmen J., Indredavik B., Terent A. Epidemiology of stroke in Innherred, Norway, 1994 to 1996. Incidence and 30-day case-fatality rate. Stroke. 1997 Nov;28(11):2180–2184. doi: 10.1161/01.str.28.11.2180. [DOI] [PubMed] [Google Scholar]
  6. Elliott P., Stamler J., Nichols R., Dyer A. R., Stamler R., Kesteloot H., Marmot M. Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. Intersalt Cooperative Research Group. BMJ. 1996 May 18;312(7041):1249–1253. doi: 10.1136/bmj.312.7041.1249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ellison R. C., Capper A. L., Stephenson W. P., Goldberg R. J., Hosmer D. W., Jr, Humphrey K. F., Ockene J. K., Gamble W. J., Witschi J. C., Stare F. J. Effects on blood pressure of a decrease in sodium use in institutional food preparation: the Exeter-Andover Project. J Clin Epidemiol. 1989;42(3):201–208. doi: 10.1016/0895-4356(89)90056-5. [DOI] [PubMed] [Google Scholar]
  8. Forte J. G., Miguel J. M., Miguel M. J., de Pádua F., Rose G. Salt and blood pressure: a community trial. J Hum Hypertens. 1989 Jun;3(3):179–184. [PubMed] [Google Scholar]
  9. Hill M. J. Salt and gastric cancer. Eur J Cancer Prev. 1998 Jun;7(3):173–175. doi: 10.1097/00008469-199806000-00001. [DOI] [PubMed] [Google Scholar]
  10. Koopmanschap M. A., Rutten F. F., van Ineveld B. M., van Roijen L. The friction cost method for measuring indirect costs of disease. J Health Econ. 1995 Jun;14(2):171–189. doi: 10.1016/0167-6296(94)00044-5. [DOI] [PubMed] [Google Scholar]
  11. Kristiansen I. S., Eggen A. E., Thelle D. S. Cost effectiveness of incremental programmes for lowering serum cholesterol concentration: is individual intervention worth while? BMJ. 1991 May 11;302(6785):1119–1122. doi: 10.1136/bmj.302.6785.1119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Njølstad I., Arnesen E. Preinfarction blood pressure and smoking are determinants for a fatal outcome of myocardial infarction: a prospective analysis from the Finnmark Study. Arch Intern Med. 1998 Jun 22;158(12):1326–1332. doi: 10.1001/archinte.158.12.1326. [DOI] [PubMed] [Google Scholar]
  13. Selmer R. Blood pressure and twenty-year mortality in the city of Bergen, Norway. Am J Epidemiol. 1992 Aug 15;136(4):428–440. doi: 10.1093/oxfordjournals.aje.a116516. [DOI] [PubMed] [Google Scholar]
  14. Sonnenberg F. A., Beck J. R. Markov models in medical decision making: a practical guide. Med Decis Making. 1993 Oct-Dec;13(4):322–338. doi: 10.1177/0272989X9301300409. [DOI] [PubMed] [Google Scholar]
  15. Staessen J., Bulpitt C. J., Fagard R., Joossens J. V., Lijnen P., Amery A. Salt intake and blood pressure in the general population: a controlled intervention trial in two towns. J Hypertens. 1988 Dec;6(12):965–973. doi: 10.1097/00004872-198812000-00003. [DOI] [PubMed] [Google Scholar]
  16. Stamler J., Stamler R., Neaton J. D. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med. 1993 Mar 8;153(5):598–615. doi: 10.1001/archinte.153.5.598. [DOI] [PubMed] [Google Scholar]
  17. Stensland-Bugge E., Bønaa K. H., Joakimsen O. Reproducibility of ultrasonographically determined intima-media thickness is dependent on arterial wall thickness. The Tromsø Study. Stroke. 1997 Oct;28(10):1972–1980. doi: 10.1161/01.str.28.10.1972. [DOI] [PubMed] [Google Scholar]
  18. Tatsuta M., Iishi H., Baba M., Uehara H., Nakaizumi A., Iseki K. Reduction in NaCl-enhanced gastric carcinogenesis in rats fed a high-protein diet. Cancer Lett. 1997 Jun 24;116(2):247–252. doi: 10.1016/s0304-3835(97)00197-3. [DOI] [PubMed] [Google Scholar]
  19. Thaler B. I., Paulin J. M., Phelan E. L., Simpson F. O. A pilot study to test the feasibility of salt restriction in a community. N Z Med J. 1982 Dec 8;95(721):839–842. [PubMed] [Google Scholar]
  20. Tosteson A. N., Weinstein M. C., Hunink M. G., Mittleman M. A., Williams L. W., Goldman P. A., Goldman L. Cost-effectiveness of populationwide educational approaches to reduce serum cholesterol levels. Circulation. 1997 Jan 7;95(1):24–30. doi: 10.1161/01.cir.95.1.24. [DOI] [PubMed] [Google Scholar]
  21. Tuomilehto J., Puska P., Tanskanen A., Karppanen H., Pietinen P., Nissinen A., Enlund H., Ruotsalainen P. A community-based intervention study on the feasibility and effects of the reduction of salt intake in North Karelia, Finland. Acta Cardiol. 1981;36(2):83–104. [PubMed] [Google Scholar]
  22. Ward M. H., López-Carrillo L. Dietary factors and the risk of gastric cancer in Mexico City. Am J Epidemiol. 1999 May 15;149(10):925–932. doi: 10.1093/oxfordjournals.aje.a009736. [DOI] [PubMed] [Google Scholar]
  23. Weinstein M. C., Stason W. B. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977 Mar 31;296(13):716–721. doi: 10.1056/NEJM197703312961304. [DOI] [PubMed] [Google Scholar]
  24. Zemel M. B. Dietary pattern and hypertension: the DASH study. Dietary Approaches to Stop Hypertension. Nutr Rev. 1997 Aug;55(8):303–305. doi: 10.1111/j.1753-4887.1997.tb05489.x. [DOI] [PubMed] [Google Scholar]
  25. Zethraeus N., Molin T., Henriksson P., Jönsson B. Costs of coronary heart disease and stroke: the case of Sweden. J Intern Med. 1999 Aug;246(2):151–159. doi: 10.1046/j.1365-2796.1999.00546.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Epidemiology and Community Health are provided here courtesy of BMJ Publishing Group

RESOURCES